Advanced Medical Solutions Group (LSE:AMS) COGS-to-Revenue : 0.45 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Advanced Medical Solutions Group COGS-to-Revenue?

Advanced Medical Solutions Group's Cost of Goods Sold for the six months ended in Dec. 2023 was £28.6 Mil. Its Revenue for the six months ended in Dec. 2023 was £63.1 Mil.

Advanced Medical Solutions Group's COGS to Revenue for the six months ended in Dec. 2023 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Advanced Medical Solutions Group's Gross Margin % for the six months ended in Dec. 2023 was 54.64%.

Advanced Medical Solutions Group COGS-to-Revenue Historical Data

The historical data trend for Advanced Medical Solutions Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Medical Solutions Group COGS-to-Revenue Chart

Advanced Medical Solutions Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.41

0.47

0.44

0.41

0.44

Advanced Medical Solutions Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.44	0.41	0.41	0.43	0.45

Advanced Medical Solutions Group COGS-to-Revenue Calculation

Advanced Medical Solutions Group's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	56.07	/	126.21
	=	0.44

Advanced Medical Solutions Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	28.635	/	63.122
	=	0.45

Advanced Medical Solutions Group (LSE:AMS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Advanced Medical Solutions Group's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	28.635 / 63.122
	=	54.64 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Advanced Medical Solutions Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Medical Solutions Group (LSE:AMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (LSE:AMS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

AMS.GB:UK AQA:Germany

Address

Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT

Website

https://www.admedsol.com

U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.